Drug Database
Back to search

Poland· PL-100282120

Jentadueto

A metformin and linagliptin product containing linagliptinum + metformini hydrochloridum, registered in Poland by Boehringer Ingelheim International GmbH. The same ATC class is registered in 13 of our 19 countries.

ATC A10BD11

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedJentaduetoATCA10BD11REGISTER NO.PL-100282120PACKS LISTED17CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about linagliptinum + metformini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Metformin and linagliptin is registered in 13 of 19 countries.

Countries holding a registration under ATC A10BD11 (metformin and linagliptin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search metformin and linagliptin products by name

Metformin and linagliptin · ATC A10BD11

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Linagliptinum + Metformini hydrochloridum
Manufacturer
Boehringer Ingelheim International GmbH
Country
Poland (PL)
ATC code
A10BD11
ATC class
Metformin and linagliptin
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 17

  • gtin
    05909990992928
  • gtin
    05909990992935
  • gtin
    05909990992843
  • gtin
    05909990992904
  • gtin
    05909990992850
  • gtin
    05909990992867
  • gtin
    05909990992874
  • gtin
    05909990992881
  • gtin
    05909990992898
  • gtin
    05909990992942
  • gtin
    05909990992959
  • gtin
    05909990992966
  • gtin
    05909990992973
  • gtin
    05909990992980
  • gtin
    05909991028947
  • gtin
    05909991028954
  • gtin
    05909991028961

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for metformin and linagliptin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check metformin and linagliptin against other medicinesHow interaction checks work

Metformin and linagliptin · interactions on record

3 records

3 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Metformin and linagliptin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and linagliptin products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Ilinpru Combi, Linagliptin/Metformin
  • Bulgaria · Ilinpru Combi, Linatin Met
  • Cyprus · Autnami, Linagliptin/Metformin Tad
  • Czechia · Linagliptin/Metformin Sandoz, Linagliptin/Metformin Stada
  • Denmark · Glymetia, Liglifev
  • Estonia · Autnami, Linagliptin/Metformin Stada
  • Spain · Linagliptina/Metformina Cinfa, Linagliptina/Metformina Combix
  • Finland · Linagliptin/Metformin Krka, Linagliptin/Metformin Sandoz
  • United Kingdom (Northern Ireland) · Linagliptin/ Metformin Hydrochloride Torrent Pharma (Uk), Linagliptin/Metformin Hydrochloride Zentiva Pharma Uk
  • Greece · Alfalib, Linagliptin+metformin Stada
  • Croatia · Autnami, Lymerexo
  • Hungary · Autnami, Ilinpru Combi
  • Ireland · Linagliptin/Metformin Hydrochloride Rowex
  • Iceland · Jentadueto
  • Italy · Linagliptin E Metformina Eg, Linagliptin E Metformina Sandoz
  • Liechtenstein · Jentadueto
  • Lithuania · Autnami, Linagliptin/Metformin Stada
  • Latvia · Autnami, Linagliptin/Metformin Stada
  • Malta · Glymetia, Linagliptin/Metformin Clonmel
  • Netherlands · Liglifev
  • Norway · Jentadueto
  • Portugal · Metformina + Linagliptina Alter, Metformina + Linagliptina Krka
  • Slovenia · Liglipexcombi, Linagliptin/Metformin Krka
  • Slovakia · Linagliptin/Metformin Sandoz, Linagliptin/Metformin Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5824c74d-3199-4d90-a5e6-2d06c712b8c0
GET /v1/drugs/5824c74d-3199-4d90-a5e6-2d06c712b8c0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "2,5 mg + 850 mg",
  "packaging": "05909990992843 ¦ Rp ¦ EU/1/12/780/001 ¦ 77914\n10 tabl.\n05909990992850 ¦ Rp ¦ EU/1/12/780/002 ¦ 77915\n14 tabl. w blistrze perforowanym\n05909990992867 ¦ Rp ¦ EU/1/12/780/003 ¦ 77916\n28 tabl.\n05909990992874 ¦ Rp ¦ EU/1/12/780/004 ¦ 77917\n30 tabl.\n05909990992881 ¦ Rp ¦ EU/1/12/780/005 ¦ 77918\n56 tabl.\n05909990992898 ¦ Rp ¦ EU/1/12/780/006 ¦ 77919\n60 tabl. w blistrze perforowanym\n05909990992904 ¦ Rp ¦ EU/1/12/780/007 ¦ 77920\n84 tabl.\n05909990992928 ¦ Rp ¦ EU/1/12/780/008 ¦ 77922\n90 tabl.\n05909990992935 ¦ Rp ¦ EU/1/12/780/009 ¦ 77923\n98 tabl.\n05909990992942 ¦ Rp ¦ EU/1/12/780/010 ¦ 77924\n100 tabl.\n05909990992959 ¦ Rp ¦ EU/1/12/780/011 ¦ 77925\n120 tabl.\n05909990992966 ¦ Rp ¦ EU/1/12/780/012 ¦ 77926\n14 tabl. w butelce\n05909990992973 ¦ Rp ¦ EU/1/12/780/013 ¦ 77927\n60 tabl. w butelce\n05909990992980 ¦ Rp ¦ EU/1/12/780/012 ¦ 77928\n180 tabl.\n05909991028947 ¦ Rp ¦ EU/1/12/780/029 ¦ 81096\n120 tabl. (2 x 60 x 1)\n05909991028954 ¦ Rp ¦ EU/1/12/780/030 ¦ 81101\n180 tabl. (2 x 90 x 1)\n05909991028961 ¦ Rp ¦ EU/1/12/780/031 ¦ 81102\n200 tabl. (2 x 100 x 1)\nRp ¦ EU/1/12/780/035 ¦ 152580\n180 tabl. (3 x 60 x 1) (dawka pojedyncza)",
  "substance": "Linagliptinum 2.5 mg + Metformini hydrochloridum 850 mg",
  "common_name": "Linagliptinum + Metformini hydrochloridum",
  "pl_product_id": "100282120",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about metformin and linagliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console